CN Patent

CN113825500A — 包含麻黄碱或麻黄碱盐的组合物及其制备和使用方法

Assigned to Nexus Pharmaceuticals Inc · Expires 2021-12-21 · 4y expired

What this patent protects

本公开提供了即刻用于临床环境中的包含硫酸麻黄碱的组合物，以及制备和使用该组合物的方法。

USPTO Abstract

本公开提供了即刻用于临床环境中的包含硫酸麻黄碱的组合物，以及制备和使用该组合物的方法。

Drugs covered by this patent

ephedrine-sulfate (EPHEDRINE SULFATE)

Patent Metadata

Patent number: CN113825500A
Jurisdiction: CN
Classification: —
Expires: 2021-12-21
Drug substance claim: No
Drug product claim: No
Assignee: Nexus Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.